rabeprazole has been researched along with Behcet Syndrome in 1 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
Behcet Syndrome: Rare chronic inflammatory disease involving the small blood vessels. It is of unknown etiology and characterized by mucocutaneous ulceration in the mouth and genital region and uveitis with hypopyon. The neuro-ocular form may cause blindness and death. SYNOVITIS; THROMBOPHLEBITIS; gastrointestinal ulcerations; RETINAL VASCULITIS; and OPTIC ATROPHY may occur as well.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xia, Q | 1 |
| Lyu, C | 1 |
| Li, F | 1 |
| Pang, B | 1 |
| Guo, X | 1 |
| Ren, H | 1 |
| Xing, Y | 1 |
| Chen, Z | 1 |
1 other study available for rabeprazole and Behcet Syndrome
| Article | Year |
|---|---|
Candidate Drugs Screening for Behcet's Disease Based on Bioinformatics Analysis and Mouse Experiments.
Topics: Animals; Behcet Syndrome; Computational Biology; Cytokines; Gene Expression Profiling; Inflammation; | 2022 |